BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11522620)

  • 1. Loss of annexin II heavy and light chains in prostate cancer and its precursors.
    Chetcuti A; Margan SH; Russell P; Mann S; Millar DS; Clark SJ; Rogers J; Handelsman DJ; Dong Q
    Cancer Res; 2001 Sep; 61(17):6331-4. PubMed ID: 11522620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of miR-936 leads to acquisition of androgen-independent metastatic phenotype in prostate cancer.
    Edachery S; Patil P; Mohan R; Aradhya B; Shetty J; Kabekkodu SP; Santra MK; Gonchigar SJ; Shetty P
    Sci Rep; 2022 Oct; 12(1):17070. PubMed ID: 36224238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.
    Vitale G; Caraglia M; Jung V; Kamradt J; Gentilini D; Di Martino MT; Dicitore A; Abate M; Tagliaferri P; Itro A; Ferro M; Balsamo R; De Sio M; Facchini G; Persani L; Schmitt K; Saar M; Stöckle M; Unteregger G; Zappavigna S
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic features of Annexin A2 expression in prostate cancer.
    Tan SH; Young D; Chen Y; Kuo HC; Srinivasan A; Dobi A; Petrovics G; Cullen J; Mcleod DG; Rosner IL; Srivastava S; Sesterhenn IA
    Pathology; 2021 Feb; 53(2):205-213. PubMed ID: 32967771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial role of Anxa2 in cancer progression: highlights on its novel regulatory mechanism.
    Wang T; Wang Z; Niu R; Wang L
    Cancer Biol Med; 2019 Nov; 16(4):671-687. PubMed ID: 31908887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.
    Noye TM; Lokman NA; Oehler MK; Ricciardelli C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.
    Beyene DA; Naab TJ; Kanarek NF; Apprey V; Esnakula A; Khan FA; Blackman MR; Brown CA; Hudson TS
    Prostate; 2018 Aug; 78(11):801-811. PubMed ID: 29682763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.
    Dunne JC; Lamb DS; Delahunt B; Murray J; Bethwaite P; Ferguson P; Nacey JN; Sondhauss S; Jordan TW
    Clin Proteomics; 2015; 12(1):24. PubMed ID: 26388710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
    Griner NB; Young D; Chaudhary P; Mohamed AA; Huang W; Chen Y; Sreenath T; Dobi A; Petrovics G; Vishwanatha JK; Sesterhenn IA; Srivastava S; Tan SH
    Mol Cancer Res; 2015 Feb; 13(2):368-79. PubMed ID: 25344575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A2: its molecular regulation and cellular expression in cancer development.
    Wang CY; Lin CF
    Dis Markers; 2014; 2014():308976. PubMed ID: 24591759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three are better than one: plasminogen receptors as cancer theranostic targets.
    Ceruti P; Principe M; Capello M; Cappello P; Novelli F
    Exp Hematol Oncol; 2013 Apr; 2(1):12. PubMed ID: 23594883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A2 heterotetramer: structure and function.
    Bharadwaj A; Bydoun M; Holloway R; Waisman D
    Int J Mol Sci; 2013 Mar; 14(3):6259-305. PubMed ID: 23519104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of annexin A2 and cancers.
    Zhang X; Liu S; Guo C; Zong J; Sun MZ
    Clin Transl Oncol; 2012 Sep; 14(9):634-40. PubMed ID: 22855149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin.
    Nakayama H; Fukuda S; Inoue H; Nishida-Fukuda H; Shirakata Y; Hashimoto K; Higashiyama S
    Mol Biol Cell; 2012 May; 23(10):1964-75. PubMed ID: 22438584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic laboratory findings in malignancy.
    Madrid FF; Maroun MC
    Rheum Dis Clin North Am; 2011 Nov; 37(4):507-25. PubMed ID: 22075195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin A2 binds RNA and reduces the frameshifting efficiency of infectious bronchitis virus.
    Kwak H; Park MW; Jeong S
    PLoS One; 2011; 6(8):e24067. PubMed ID: 21918681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of annexin A2 in tumorigenesis and cancer progression.
    Lokman NA; Ween MP; Oehler MK; Ricciardelli C
    Cancer Microenviron; 2011 Aug; 4(2):199-208. PubMed ID: 21909879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
    Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
    Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Annexin II represents metastatic potential in clear-cell renal cell carcinoma.
    Ohno Y; Izumi M; Kawamura T; Nishimura T; Mukai K; Tachibana M
    Br J Cancer; 2009 Jul; 101(2):287-94. PubMed ID: 19513064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.
    Song J; Shih IeM; Chan DW; Zhang Z
    Neoplasia; 2009 Jun; 11(6):605-14, 1 p following 614. PubMed ID: 19484149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.